Genetic Technology Alert. Discovery of Gene Type Associated with ALS Disorder; Genetic Pathway for a Rare Tumor of the Brain Identified; Signaling Pathway for Pancreatic Cancer Established

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles discovery of gene type associated with ALS disorder, identification of genetic pathway for a rare tumor of the brain; and discovery of a signaling pathway for pancreatic cancer .

Table of Contents

Genetic Technology Alert. Discovery of Gene Type Associated with ALS Disorder; Genetic Pathway for a Rare Tumor of the Brain Identified; Signaling Pathway for Pancreatic Cancer EstablishedIn This Issue1. DISCOVERY OF GENE TYPE ASSOCIATED WITH ALS DISORDER2. GENETIC PATHWAY FOR A RARE TUMOR OF THE BRAIN IDENTIFIED3. SIGNALING PATHWAY FOR PANCREATIC CANCER ESTABLISHED4. PATENTS ON TREATMENT OPTIONS FOR DUCHENNE MUSCULAR DYSTROPHY




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.